HLA-B27-associated uveitis: Overview and current perspectives

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purpose of review: To review current knowledge about the pathogenesis, clinical presentation, and treatment of HLA-B27-associated uveitis, which is the most commonly identified cause of uveitis in community-based practice and an important cause of ocular morbidity. Recent findings: Significant advances have been made in understanding the pathogenesis of HLA-B27-associated ocular and systemic disease, especially with regard to the genetic underpinning of these diseases. Increasing attention has also been focused on the use of alternative therapies in the treatment of HLA-B27-associated uveitis, with special attention to sulfa class antibiotics, historically have been used to treat the articular manifestations of the spondyloarthritides, and newer drugs that inhibit tumor necrosis factor-α. Summary: The next several years promise to yield exciting new advances in understanding of the genetic epidemiology and treatment of HLA-B27-associated uveitis.

Original languageEnglish (US)
Pages (from-to)378-383
Number of pages6
JournalCurrent Opinion in Ophthalmology
Volume14
Issue number6
DOIs
StatePublished - Dec 2003

Fingerprint

HLA-B27 Antigen
Uveitis
Inborn Genetic Diseases
Molecular Epidemiology
Eye Diseases
Complementary Therapies
Therapeutics
Tumor Necrosis Factor-alpha
Joints
Anti-Bacterial Agents
Morbidity
Pharmaceutical Preparations

Keywords

  • Genetics
  • HLA-B27
  • Seronegative spondyloarthropathy
  • Tumor necrosis factor-α
  • Uveitis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

HLA-B27-associated uveitis : Overview and current perspectives. / Suhler, Eric; Martin, Tammy; Rosenbaum, James (Jim).

In: Current Opinion in Ophthalmology, Vol. 14, No. 6, 12.2003, p. 378-383.

Research output: Contribution to journalArticle

@article{9b4c7cf456c0441989b974871d8cd6b3,
title = "HLA-B27-associated uveitis: Overview and current perspectives",
abstract = "Purpose of review: To review current knowledge about the pathogenesis, clinical presentation, and treatment of HLA-B27-associated uveitis, which is the most commonly identified cause of uveitis in community-based practice and an important cause of ocular morbidity. Recent findings: Significant advances have been made in understanding the pathogenesis of HLA-B27-associated ocular and systemic disease, especially with regard to the genetic underpinning of these diseases. Increasing attention has also been focused on the use of alternative therapies in the treatment of HLA-B27-associated uveitis, with special attention to sulfa class antibiotics, historically have been used to treat the articular manifestations of the spondyloarthritides, and newer drugs that inhibit tumor necrosis factor-α. Summary: The next several years promise to yield exciting new advances in understanding of the genetic epidemiology and treatment of HLA-B27-associated uveitis.",
keywords = "Genetics, HLA-B27, Seronegative spondyloarthropathy, Tumor necrosis factor-α, Uveitis",
author = "Eric Suhler and Tammy Martin and Rosenbaum, {James (Jim)}",
year = "2003",
month = "12",
doi = "10.1097/00055735-200312000-00010",
language = "English (US)",
volume = "14",
pages = "378--383",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - HLA-B27-associated uveitis

T2 - Overview and current perspectives

AU - Suhler, Eric

AU - Martin, Tammy

AU - Rosenbaum, James (Jim)

PY - 2003/12

Y1 - 2003/12

N2 - Purpose of review: To review current knowledge about the pathogenesis, clinical presentation, and treatment of HLA-B27-associated uveitis, which is the most commonly identified cause of uveitis in community-based practice and an important cause of ocular morbidity. Recent findings: Significant advances have been made in understanding the pathogenesis of HLA-B27-associated ocular and systemic disease, especially with regard to the genetic underpinning of these diseases. Increasing attention has also been focused on the use of alternative therapies in the treatment of HLA-B27-associated uveitis, with special attention to sulfa class antibiotics, historically have been used to treat the articular manifestations of the spondyloarthritides, and newer drugs that inhibit tumor necrosis factor-α. Summary: The next several years promise to yield exciting new advances in understanding of the genetic epidemiology and treatment of HLA-B27-associated uveitis.

AB - Purpose of review: To review current knowledge about the pathogenesis, clinical presentation, and treatment of HLA-B27-associated uveitis, which is the most commonly identified cause of uveitis in community-based practice and an important cause of ocular morbidity. Recent findings: Significant advances have been made in understanding the pathogenesis of HLA-B27-associated ocular and systemic disease, especially with regard to the genetic underpinning of these diseases. Increasing attention has also been focused on the use of alternative therapies in the treatment of HLA-B27-associated uveitis, with special attention to sulfa class antibiotics, historically have been used to treat the articular manifestations of the spondyloarthritides, and newer drugs that inhibit tumor necrosis factor-α. Summary: The next several years promise to yield exciting new advances in understanding of the genetic epidemiology and treatment of HLA-B27-associated uveitis.

KW - Genetics

KW - HLA-B27

KW - Seronegative spondyloarthropathy

KW - Tumor necrosis factor-α

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=1542407379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542407379&partnerID=8YFLogxK

U2 - 10.1097/00055735-200312000-00010

DO - 10.1097/00055735-200312000-00010

M3 - Article

C2 - 14615643

AN - SCOPUS:1542407379

VL - 14

SP - 378

EP - 383

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 6

ER -